Psychopharmacology and Psychiatry Updates

En podcast av Psychopharmacology Institute

Kategorier:

265 Avsnitt

  1. SSRIs and Anticoagulants: Navigating Bleeding Risk

    Publicerades: 2025-03-12
  2. Lamotrigine and the Heart: What You Need to Know

    Publicerades: 2025-03-07
  3. After the Last Dose: Understanding Antipsychotic Discontinuation

    Publicerades: 2025-03-02
  4. Understanding Lamotrigine's Cardiac Effects

    Publicerades: 2025-02-25
  5. Rethinking Falls: Are Sleep Medications Really to Blame?

    Publicerades: 2025-02-20
  6. Navigating Lamotrigine's Side Effects

    Publicerades: 2025-02-15
  7. Iloperidone in Bipolar Disorder: A New Treatment Option?

    Publicerades: 2025-02-10
  8. Lamotrigine: Pearls for Prescribing

    Publicerades: 2025-02-05
  9. Beyond Benzos: New Frontiers in Agitation Management

    Publicerades: 2025-01-31
  10. KarXT: A New Dawn in Antipsychotic Treatment

    Publicerades: 2025-01-26
  11. Rethinking Agitation Management: From Force to Partnership

    Publicerades: 2025-01-21
  12. COVID Brain Fog: Repurposing Famotidine

    Publicerades: 2025-01-16
  13. Beyond Restraints: De-Escalation in Behavioral Emergencies

    Publicerades: 2025-01-11
  14. Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial

    Publicerades: 2025-01-06
  15. Unraveling Agitation: Mania vs. Substance Use

    Publicerades: 2025-01-01
  16. Pushing the Boundaries: Exploring High-Dose Antipsychotics

    Publicerades: 2024-12-27
  17. The Psychodynamic Prescriber

    Publicerades: 2024-12-22
  18. From Inpatient to Outpatient: Initiating Benzodiazepine Tapering

    Publicerades: 2024-12-17
  19. The Power of Alliance in Psychopharmacology

    Publicerades: 2024-12-12
  20. Antipsychotics in Youth: Balancing Metabolic Risk

    Publicerades: 2024-12-07

1 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site